BioSyent Inc. (RX.V) TSXV

11.30

-0.1(-0.88%)

Updated at August 18 03:48PM

Currency In CAD

Valuation

Market Cap127.45M
Enterprise Value116.38M
P/E Ratio16.28
PEG Ratio1.71
Price/Sales Ratio3.39
Price/Book Ratio3.54
Enterprise/Revenue3.13
Enterprise/EBITDA10.62

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.2
Operating Margin0.25

Management Effectiveness

Return On Assets0.18
Return On Equity0.22

Income Statement

Revenue35.03M
Revenue/Share3.4
Gross Profit27.86M
EBITDA10.43M
Net Income7.27M
Diluted EPS0.62

Balance Sheet

Total Cash17.4M
Total Cash/Share1.54
Total Debt990,218
Total Debt/Equity0.03
Current Ratio4.9
Book Value Per Share3.2

Price History

52-Week Change13.34
52-Week High12.13
52-Week Low9.2
Moving Average 50 Days11.63
Moving Average 200 Days11.24

Statistics

Average Volume2,648
Shares Outstanding11.47M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.19
Trailing Annual Dividend Yield1.68
Payout Ratio0.27
Last Split FactorN/A
Last Split DateN/A